AQST Q3 2020 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$8M-33.5% YoY

Gross Profit

$5M63.9% margin

Operating Income

-$14M-166.8% margin

Net Income

-$17M-200.4% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-61.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$87M

Stockholders' Equity

-$37M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$12M	-33.5%
Gross Profit	$5M	$8M	-32.1%
Operating Income	-$14M	-$11M	-25.3%
Net Income	-$17M	-$18M	+10.1%

Revenue Segments

Manufacture and Supply Revenue

$6M95%

License and Royalty Revenue

$328,0005%